126 related articles for article (PubMed ID: 31689526)
1. Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization.
Fowlkes JL; Bunn RC; Ray PD; Kalaitzoglou E; Uppuganti S; Unal M; Nyman JS; Thrailkill KM
Bone; 2020 Jan; 130():115106. PubMed ID: 31689526
[TBL] [Abstract][Full Text] [Related]
2. Somatic activating mutations in MAP2K1 cause melorheostosis.
Kang H; Jha S; Deng Z; Fratzl-Zelman N; Cabral WA; Ivovic A; Meylan F; Hanson EP; Lange E; Katz J; Roschger P; Klaushofer K; Cowen EW; Siegel RM; Marini JC; Bhattacharyya T
Nat Commun; 2018 Apr; 9(1):1390. PubMed ID: 29643386
[TBL] [Abstract][Full Text] [Related]
3. Melorheostotic Bone Lesions Caused by Somatic Mutations in MAP2K1 Have Deteriorated Microarchitecture and Periosteal Reaction.
Fratzl-Zelman N; Roschger P; Kang H; Jha S; Roschger A; Blouin S; Deng Z; Cabral WA; Ivovic A; Katz J; Siegel RM; Klaushofer K; Fratzl P; Bhattacharyya T; Marini JC
J Bone Miner Res; 2019 May; 34(5):883-895. PubMed ID: 30667555
[TBL] [Abstract][Full Text] [Related]
4. VEGF Secretion Drives Bone Formation in Classical MAP2K1+ Melorheostosis.
Allbritton-King JD; Maity J; Patel A; Colbert RA; Navid F; Bhattacharyya T
J Bone Miner Res; 2023 Dec; 38(12):1834-1845. PubMed ID: 37737377
[TBL] [Abstract][Full Text] [Related]
5. Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.
Jha S; Fratzl-Zelman N; Roschger P; Papadakis GZ; Cowen EW; Kang H; Lehky TJ; Alter K; Deng Z; Ivovic A; Flynn L; Reynolds JC; Dasgupta A; Miettinen M; Lange E; Katz J; Klaushofer K; Marini JC; Siegel RM; Bhattacharyya T
J Bone Miner Res; 2019 Jan; 34(1):145-156. PubMed ID: 30138550
[TBL] [Abstract][Full Text] [Related]
6. Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.
Kang H; Jha S; Ivovic A; Fratzl-Zelman N; Deng Z; Mitra A; Cabral WA; Hanson EP; Lange E; Cowen EW; Katz J; Roschger P; Klaushofer K; Dale RK; Siegel RM; Bhattacharyya T; Marini JC
J Exp Med; 2020 May; 217(5):. PubMed ID: 32232430
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of 10 Chinese patients with melorheostosis and identification of a somatic MAP2K1 variant in one case.
Han X; Xu Y; Wei Z; Wang C; Yue H; Zhang Z
Mol Genet Genomic Med; 2022 Oct; 10(10):e2043. PubMed ID: 36004822
[TBL] [Abstract][Full Text] [Related]
8. Integrin-Linked Kinase Regulates Bone Formation by Controlling Cytoskeletal Organization and Modulating BMP and Wnt Signaling in Osteoprogenitors.
Dejaeger M; Böhm AM; Dirckx N; Devriese J; Nefyodova E; Cardoen R; St-Arnaud R; Tournoy J; Luyten FP; Maes C
J Bone Miner Res; 2017 Oct; 32(10):2087-2102. PubMed ID: 28574598
[TBL] [Abstract][Full Text] [Related]
9. CT analysis of anatomical distribution of melorheostosis challenges the sclerotome hypothesis.
Jha S; Laucis N; Kim L; Malayeri A; Dasgupta A; Papadakis GZ; Karantanas A; Torres M; Bhattacharyya T
Bone; 2018 Dec; 117():31-36. PubMed ID: 30218789
[TBL] [Abstract][Full Text] [Related]
10. Histopathological characterization of melorheostosis.
Hoshi K; Amizuka N; Kurokawa T; Nakamura K; Shiro R; Ozawa H
Orthopedics; 2001 Mar; 24(3):273-7. PubMed ID: 11300293
[TBL] [Abstract][Full Text] [Related]
11. A multi-omics approach expands the mutational spectrum of MAP2K1-related melorheostosis.
De Ridder R; Boudin E; Zillikens MC; Ibrahim J; van der Eerden BCJ; Van Hul W; Mortier G
Bone; 2020 Aug; 137():115406. PubMed ID: 32387835
[TBL] [Abstract][Full Text] [Related]
12. Melorheostosis and Osteopoikilosis: A Review of Clinical Features and Pathogenesis.
Wordsworth P; Chan M
Calcif Tissue Int; 2019 May; 104(5):530-543. PubMed ID: 30989250
[TBL] [Abstract][Full Text] [Related]
13. The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis.
Kim JM; Yang YS; Park KH; Oh H; Greenblatt MB; Shim JH
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013682
[TBL] [Abstract][Full Text] [Related]
14. The role of MEK1/2 and MEK5 in melatonin-mediated actions on osteoblastogenesis, osteoclastogenesis, bone microarchitecture, biomechanics, and bone formation.
Munmun F; Mohiuddin OA; Hoang VT; Burow ME; Bunnell BA; Sola VM; Carpentieri AR; Witt-Enderby PA
J Pineal Res; 2022 Sep; 73(2):e12814. PubMed ID: 35674448
[TBL] [Abstract][Full Text] [Related]
15. Melorheostosis: a Rare Sclerosing Bone Dysplasia.
Kotwal A; Clarke BL
Curr Osteoporos Rep; 2017 Aug; 15(4):335-342. PubMed ID: 28676968
[TBL] [Abstract][Full Text] [Related]
16. Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.
Kresinsky A; Schnöder TM; Jacobsen ID; Rauner M; Hofbauer LC; Ast V; König R; Hoffmann B; Svensson CM; Figge MT; Hilger I; Heidel FH; Böhmer FD; Müller JP
Oncogene; 2019 Jun; 38(24):4773-4787. PubMed ID: 30820040
[TBL] [Abstract][Full Text] [Related]
17. Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue.
Jepsen KJ; Schaffler MB; Kuhn JL; Goulet RW; Bonadio J; Goldstein SA
J Biomech; 1997; 30(11-12):1141-7. PubMed ID: 9456382
[TBL] [Abstract][Full Text] [Related]
18. Identification of dexamethasone-dependent osteoprogenitors in cell populations derived from adult human female bone.
Pei W; Yoshimine Y; Heersche JN
Calcif Tissue Int; 2003 Feb; 72(2):124-34. PubMed ID: 12415421
[TBL] [Abstract][Full Text] [Related]
19. Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.
Nordstrom SM; Carleton SM; Carson WL; Eren M; Phillips CL; Vaughan DE
Bone; 2007 Dec; 41(6):995-1004. PubMed ID: 17888748
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
Murakami S; Balmes G; McKinney S; Zhang Z; Givol D; de Crombrugghe B
Genes Dev; 2004 Feb; 18(3):290-305. PubMed ID: 14871928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]